

Ear, Nose and Throat Disorders
Volume 8
Otolaryngology: Open Access
ENT Conference 2018
May 14-15, 2018
Page 24
Notes:
conference
series
.com
May 14-15, 2018 Osaka, Japan
2
nd
International Conference on
Updates in tinnitus -can biomodulation be a safe and easy way for relief?
T
innitus is a global problem with significant healthcare costs and a complex central origin. There is a lack of evidence-based,
non-expensive and risk-free treatments that are also not time consuming, especially for those with mild to moderate
symptoms. Coherent brain activity is seen in healthy subjects without awareness of tinnitus in a quiet and calm environment
in resting state recordings. On the contrary, sufferers of tinnitus are characterized by hyperactivity in the auditory cortex and
a changed global brain network. Important increased activation in networks involving the auditory cortex and amygdala have
been seen in imaging studies of subjects with tinnitus. This indicates that coherency is an important factor in maintaining
a non-tinnitus equilibrium in the hearing system for humans. The steady state biomodulator patch is a Swedish innovation
with a patented microscopic fractal and Fourier transforming raster that generates a low frequency, coherent invisible light
with higher organization, that affects water in general. This raster turns ordinary water into a coherent and more organized
form, creating a spreading self-organization process, which relates on a long-range correlation between water molecules. The
hypothesis is that the biomodulator patch can stabilize and desensitize the auditory system by creating an overall coherency,
thus resulting in tinnitus relief.
Biography
Peter Åhnblad has completed MD from Karolinska Institute in 1993 and is a trained ENT specialist with degree in 2000 from Karolinska University Hospital. He is
the founder and chief phycisian of the ENT clinic Sickla ÖNH-center. He is the principle investigator of the clinical study program with the biomodulator since 2010
with several publications.
peter@supramed.sePeter Ahnblad
Sickla ÖNH-center, Sweden
Peter Ahnblad, Otolaryngol (Sunnyvale) 2018, Volume 8
DOI: 10.4172/2161-119X-C1-024